Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma

Kelly C. Goldsmith, Michelle Gross, Susan Peirce, Dema Luyindula, Xueyuan Liu, Annette Vu, Michael Sliozberg, Rong Guo, Huaqing Zhao, C. Patrick Reynolds, Michael D. Hogarty

Cancer Res (2012) 72 (10): 2565–2577.

https://doi.org/10.1158/0008-5472.CAN-11-3603

Published: 14 May 2012

View articletitled, Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma

Includes: Supplementary data

Journal Articles

Abstract 4848: A synthetic-lethal screen identifies novel Mcl1 regulators in neuroblastoma

Theodore Laetsch, Xueyuan Liu, Michael Sliozberg, Michael Vido, Annette Vu, Kelly Goldsmith, Michael D. Hogarty

Cancer Res (2012) 72 (8_Supplement): 4848.

https://doi.org/10.1158/1538-7445.AM2012-4848

Published: 15 April 2012

View articletitled, Abstract 4848: A synthetic-lethal screen identifies novel Mcl1 regulators in neuroblastoma

Journal Articles

Abstract 5252: BH3 profiling identifies apoptosis resistance heterogeneity in neuroblastoma and predicts in vivo potency of Bcl2 antagonists

Kelly C. Goldsmith, Michelle Gross, Xueyuan Liu, Susan K. Peirce, Chengyu Prince, Michael D. Hogarty

Cancer Res (2010) 70 (8_Supplement): 5252.

https://doi.org/10.1158/1538-7445.AM10-5252

Published: 15 April 2010

View articletitled, Abstract 5252: BH3 profiling identifies apoptosis resistance heterogeneity in neuroblastoma and predicts in vivo potency of Bcl2 antagonists

Journal Articles

Abstract #3269: RNA interference reveals heterogeneous pro-survival BH protein addiction and therapy resistance patterns in neuroblastoma

Brian Lestini, Kelly Goldsmith, Niel Chen, Xueyuan Liu, Michael Hogarty

Cancer Res (2009) 69 (9_Supplement): 3269.

Published: 01 May 2009

View articletitled, Abstract #3269: RNA interference reveals heterogeneous pro-survival BH protein addiction and therapy resistance patterns in neuroblastoma

Journal Articles

Abstract #3203: Dual Targeting of AMD1 and ODC1 potently inhibits neuroblastoma initiation in vitro and in vivo

Nicholas Evageliou, Annette Vu, Xueyuan Liu, Rosalind Manning, Candace Hayes, Murray Norris, Glenn Marshall, Michelle Haber, Susan Gilmour, Michael Hogarty

Cancer Res (2009) 69 (9_Supplement): 3203.

Published: 01 May 2009

View articletitled, Abstract #3203: Dual Targeting of AMD1 and ODC1 potently inhibits neuroblastoma initiation in vitro and in vivo

Journal Articles

ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Cancer Res (2008) 68 (23): 9735–9745.

https://doi.org/10.1158/0008-5472.CAN-07-6866

Published: 01 December 2008

View articletitled, ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

Includes: Supplementary data

Journal Articles

BH3 response profiles from isolated neuroblastoma mitochondria predict sensitivity to discrete BH antagonists

Kelly Goldsmith, Brian Lestini, Ashish Bhumbla, Laura Ip, Bruce Pawel, Xueyuan Liu, Michael Hogarty

Cancer Res (2008) 68 (9_Supplement): 1626.

Published: 01 May 2008

View articletitled, BH3 response profiles from isolated neuroblastoma mitochondria predict sensitivity to discrete BH antagonists

Journal Articles

Polyamine depletion strategies to impede neuroblastoma progression

Nicholas Evageliou, Kim Davis, Xueyuan Liu, Rosalind Barr, Candace Hayes, Murray Norris, Glenn Marshall, Michelle Haber, Susan Gilmour, Michael Hogarty

Cancer Res (2008) 68 (9_Supplement): 3000.

Published: 01 May 2008

View articletitled, Polyamine depletion strategies to impede neuroblastoma progression

Journal Articles

N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells

Alexey Ushmorov, Michael Hogarty, Xueyuan Liu, Helgard Knauss, Klaus-Michael Debatin, Christian Beltinger

Cancer Res (2008) 68 (9_Supplement): 3441.

Published: 01 May 2008

View articletitled, N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells

Journal Articles

Mcl1 is the predominant pro-survival protein in neuroblastoma

Mark Fluchel, Agueda Lin, Kelly Goldsmith, Xueyuan Liu, Kim Davis, Ashish Bhumbla, Laura Ip, Wendy London, Michael Hogarty

Cancer Res (2007) 67 (9_Supplement): 5138.

Published: 01 May 2007

View articletitled, Mcl1 is the predominant pro-survival protein in neuroblastoma

Journal Articles

BH3-domain peptides synergize with cytotoxic agents to restore apoptosis sensitivity in chemoresistant neuroblastoma

Kelly Goldsmith, xueyuan Liu, Bella Goyal, Ageuda Lin, Charlene Thambinayagan, Kimberly Davis, Michael Hogarty

Cancer Res (2006) 66 (8_Supplement): 959.

Published: 15 April 2006

View articletitled, BH3-domain peptides synergize with cytotoxic agents to restore apoptosis sensitivity in chemoresistant neuroblastoma

Journal Articles

Modified BH3-domain peptides effectively activate apoptosis in neuroblastoma-derived cell lines in vitro

Kelly C. Goldsmith, Xueyuan Liu, Vincent Dam, Brian Morgan, Michael D. Hogarty

Cancer Res (2004) 64 (7_Supplement): 1286.

Published: 01 April 2004

View articletitled, Modified BH3-domain peptides effectively activate apoptosis in neuroblastoma-derived cell lines in vitro

Journal Articles

No Evidence for the Presence of an Imprinted Neuroblastoma Suppressor Gene within Chromosome Sub-Band 1p36.3

Michael D. Hogarty, Cynthia L. Winter, Xueyuan Liu, Chun Guo, Peter S. White, A. Thomas Look, Garrett M. Brodeur, John M. Maris

Cancer Res (2002) 62 (22): 6481–6484.

Published: 15 November 2002

View articletitled, No Evidence for the Presence of an Imprinted Neuroblastoma Suppressor Gene within Chromosome Sub-Band 1p36.3

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma

Abstract 4848: A synthetic-lethal screen identifies novel Mcl1 regulators in neuroblastoma

Abstract 5252: BH3 profiling identifies apoptosis resistance heterogeneity in neuroblastoma and predicts in vivo potency of Bcl2 antagonists

Abstract #3269: RNA interference reveals heterogeneous pro-survival BH protein addiction and therapy resistance patterns in neuroblastoma

Abstract #3203: Dual Targeting of AMD1 and ODC1 potently inhibits neuroblastoma initiation in vitro and in vivo

ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

BH3 response profiles from isolated neuroblastoma mitochondria predict sensitivity to discrete BH antagonists

Polyamine depletion strategies to impede neuroblastoma progression

N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells

Mcl1 is the predominant pro-survival protein in neuroblastoma

BH3-domain peptides synergize with cytotoxic agents to restore apoptosis sensitivity in chemoresistant neuroblastoma

Modified BH3-domain peptides effectively activate apoptosis in neuroblastoma-derived cell lines in vitro

No Evidence for the Presence of an Imprinted Neuroblastoma Suppressor Gene within Chromosome Sub-Band 1p36.3

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only